Kyongbo Pharmaceutical Co., Ltd Stock: price and insider trades · South Korea
경보제약
No insider purchase over the last 90 days. The latest, by 홍성상, was filed 19 Mar 2026.
Key facts
Headquarters: Asan, South Korea · Founded: 1987
Source: Wikidata (CC0).
Who traded when
BuySale+1 other insider
Since the insiders bought
- -28.1%Entry ₩7,150 · Close 30 Oct 2026 ₩5,140
- -7.6%Entry ₩5,560 · Close 30 Oct 2026 ₩5,140
- -16.6%Entry ₩6,160 · Close 30 Oct 2026 ₩5,140
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 2,000 shares@ ₩5,535.000.0084% mcap100.0% of flowShareKRXDART:20260319001207Canonical exit: 15 Jun 2026 (T+90)
- 200 shares@ ₩5,730.000.0009% mcap100.0% of flowShareKRXDART:20260305000992Canonical exit: 3 Jun 2026 (T+90)
- 3,000 sharesShareKRXDART:20260227007344Canonical exit: 28 May 2026 (T+90)
- ●Executives0DART
- 1,000 sharesKRXDART:20260211000546Canonical exit: 6 May 2026 (T+90)
- 1,000 sharesShareKRXDART:20260211000536Canonical exit: 12 May 2026 (T+90)
- 1,000 sharesKRXDART:20250702000467Canonical exit: 25 Sept 2025 (T+90)
- 1,000 sharesShareKRXDART:20250702000444Canonical exit: 30 Sept 2025 (T+90)
- 100 sharesShareKRXDART:20250528000168Canonical exit: 26 Aug 2025 (T+90)
- 100 sharesShareKRXDART:20250507000459Canonical exit: 5 Aug 2025 (T+90)
- 990 sharesShareKRXDART:20250425000722Canonical exit: 24 Jul 2025 (T+90)
- 2,001 sharesKRXDART:20250409001510Canonical exit: 1 Jul 2025 (T+90)
- 1,000 sharesShareKRXDART:20250409001302Canonical exit: 8 Jul 2025 (T+90)
- 1,001 sharesShareKRXDART:20250409001325Canonical exit: 8 Jul 2025 (T+90)
- 233 sharesShareKRXDART:20250210000230Canonical exit: 11 May 2025 (T+90)
- 5,000 sharesKRXDART:20250109000410Canonical exit: 3 Apr 2025 (T+90)
- 3,000 sharesShareKRXDART:20250109000230Canonical exit: 9 Apr 2025 (T+90)
- 2,000 sharesShareKRXDART:20250109000240Canonical exit: 9 Apr 2025 (T+90)
- 767 sharesShareKRXDART:20250109000357Canonical exit: 9 Apr 2025 (T+90)
- 4,873 sharesShareKRXDART:20250109000256Canonical exit: 9 Apr 2025 (T+90)
- ShareKRXDART:20230324000259
- ShareKRXDART:20230324000684
- 5,000 sharesKRXDART:20230324000716Canonical exit: 22 Jun 2023 (T+90)
- 5,000 sharesKRXDART:20230324000449Canonical exit: 22 Jun 2023 (T+90)
- ●Executives0DART
25 of 29 declarations
About Kyongbo Pharmaceutical Co., Ltd
At 경보제약 (Kyongbo Pharmaceutical Co., Ltd), a Korean health care company on the Korea Exchange, no open-market sale appears: all 23 trades are purchases. The market capitalisation is KRW 125.5 billion and insiders and declared holders own 61.8% of the capital.
The largest block comes from 종근당홀딩스 (대량보유자, large holder), with 8 filings and 8 purchases. Next are 김태영 (대표이사) with 6 filings, 정희록 (이사, director) with 5 purchases and 김도경 (감사, auditor) with 3. Two purchases carry an amount: EUR 6,454 by 홍성상 (상무) on March 17, 2026, then EUR 674 by 정희록 on March 5, 2026, EUR 7,128 in total.
Read moreShow less
From January 3 to January 9, 2025, 5 filers bought. That year accounts for 14 of the 29 filings published between August 16, 2022 and March 19, 2026, against 4 in 2022 and 6 in 2026. Over the last twelve months there are 6 filings, 5 of them purchases. Filings appear a median of 6 days after the trade.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
